Trixeo Aerosphere is a medicine used to treat patients with moderate to severe chronic obstructive pulmonary disease (COPD), a long-term disease in which the airways and air sacs in the lungs become damaged or blocked, leading to difficulty breathing. Trixeo Aerosphere is used for maintenance (regular) treatment in adults whose disease is not controlled well enough with a combination of inhaled medicines consisting of a long-acting beta-2 agonist plus either a corticosteroid or a long-acting muscarinic antagonist. Trixeo Aerosphere contains the active substances formoterol, glycopyrronium bromide and budesonide.
Therapeutic Indication
### Therapeutic indication Trixeo Aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (COPD) who are not adequately treated by a combination of an inhaled corticosteroid and a long acting beta2 agonist or combination of a long-acting beta2 agonist and a long acting muscarinic antagonist.
Therapeutic Area (MeSH)
ATC Code
R03AL
ATC Item
抗胆碱能与抗胆碱能结合/三重组合与糖皮质激素
Pharmacotherapeutic Group
Drugs for obstructive airway diseases
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| formoterol fumarate dihydrate | N/A | Aluminum sulfate |
| Glycopyrronium bromide | N/A | 格隆溴铵 |
| Budesonide | N/A | 布地奈德 |
| glycopyrronium bromide | N/A | 格隆溴铵 |
EMA Name
Trixeo Aerosphere
Medicine Name
Trixeo Aerosphere
Aliases
N/A
